Samuel Medica

  • Current Student, 2021 Cohort
  • Graduate Program in Biomedical Sciences Students, School of Medicine

Biography

Research Interests: studying the mechanisms behind human cytomegalovirus (HCMV) latency and reactivation. Specifically, he is interested in the ectopically expressed viral G-protein coupled receptor (GPCR) US28, which has been shown to drive latency, differentiation, and reactivation in hematopoietic progenitor cell reservoirs. His project involves characterization of the US28 “interactome” to identify cellular signaling pathways that maintain latency and facilitate viral reactivation. In addition to characterizing the interactome, he hopes to use Daniel Streblow Lab's targets to identify novel therapeutics inhibiting the downstream effectors of US28.

Education and training

    • B.S., Oregon State University

Publications

Publications

  • {{ pub.journalAssociation.journal.name.text[0].value }}